Surfactant proteins in pediatric interstitial lung disease

Pediatric Research

Volumn 79, Issue 1, 2016, Pages 34-41

  Griese, Matthias ^a   Lorenz, Elke ^a   Hengst, Meike ^a   Schams, Andrea ^a   Wesselak, Traudl ^a   Rauch, Daniela ^a   Wittmann, Thomas ^a   Kirchberger, Valerie ^b   Escribano, Amparo ^c   Schaible, Thomas ^d   Baden, Winfried ^e   Schulze, Johannes ^f   Krude, Heiko ^b   Aslanidis, Charalampos ^g   Schwerk, Nicolaus ^h   Kappler, Matthias ^a   Hartl, Dominik ⁱ   Lohse, Peter ^j   Zarbock, Ralf ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^f GOETHE UNIVERSITY   (Germany)

^g UNIVERSITY OF REGENSBURG   (Germany)

^h HANNOVER MEDICAL SCHOOL   (Germany)

ⁱ UNIVERSITY OF TÜBINGEN   (Germany)

^j CEGAT GMBH   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; PROTEIN ABCA3; PROTEIN SFTPC; PROTEIN TTF1; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; UNCLASSIFIED DRUG; ABC TRANSPORTER; ABCA3 PROTEIN, HUMAN; DNA BINDING PROTEIN; PROTEIN PRECURSOR; PROTEOLIPID; SFTPC PROTEIN, HUMAN; SURFACTANT PROTEIN B PROPEPTIDE; TTF1 PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; BRONCHOALVEOLAR LAVAGE FLUID; CHILD; CHILDREN INTERSTITIAL LUNG DISEASE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC REGULATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTERSTITIAL LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSIS; NEUTROPHIL COUNT; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN METABOLISM; SINGLE NUCLEOTIDE POLYMORPHISM; WESTERN BLOTTING; BRONCHITIS; CASE CONTROL STUDY; CHEMISTRY; COMORBIDITY; COMPARATIVE STUDY; DEFICIENCY; DEVELOPMENTAL DISORDER; DNA SEQUENCE; GENETIC HETEROGENEITY; GENETICS; IMMUNE DEFICIENCY; INFANT; LUNG DISEASES, INTERSTITIAL; PRESCHOOL CHILD; PULMONARY ALVEOLAR PROTEINOSIS; YOUNG ADULT;

ADOLESCENT; ATP-BINDING CASSETTE TRANSPORTERS; BRONCHITIS; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COMORBIDITY; DEVELOPMENTAL DISABILITIES; DNA-BINDING PROTEINS; FEMALE; GENETIC HETEROGENEITY; GENOTYPE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; LUNG DISEASES, INTERSTITIAL; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROTEIN PRECURSORS; PROTEOLIPIDS; PULMONARY ALVEOLAR PROTEINOSIS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B; PULMONARY SURFACTANT-ASSOCIATED PROTEIN C; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84955582484     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2015.173     Document Type: Article

References (39)

1. Griese M, Haug M, Brasch F, et al. Incidence and classifcation of pediat-ric difuse parenchymal lung diseases in Germany. Orphanet J Rare Dis 2009;4:26.
2. Clement A; ERS Task Force. Task force on chronic interstitial lung disease in immunocompetent children. Eur Respir J 2004;24:686-97.
3. Kurland G, Deterding RR, Hagood JS, et al.; American Toracic Society Committee on Childhood Interstitial Lung Disease (chILD) and the chILD Research Network. An ofcial American Toracic Society clinical practice guideline: classifcation, evaluation, and management of childhood interstitial lung disease in infancy. Am J Respir Crit Care Med 2013;188:376-94.
4. Bush A, Anthony G, Barbato A, et al.; ch-ILD collaborators. Research in progress: put the orphanage out of business. Torax 2013;68:971-3.
5. Hamvas A. Evaluation and management of inherited disorders of surfactant metabolism. Chin Med J (Engl) 2010;123:2943-7.
6. Deutsch GH, Young LR, Deterding RR, et al.; Pathology Cooperative Group; ChILD Research Co-operative. Difuse lung disease in young children: application of a novel classifcation scheme. Am J Respir Crit Care Med 2007;176:1120-8.
7. Nogee LM, de Mello DE, Dehner LP, Colten HR. Brief report: defciency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med 1993;328:406-10.
8. Nogee LM, Dunbar AE 3rd, Wert SE, Askin F, Hamvas A, Whitsett JA. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 2001;344:573-9.
9. Weaver TE, Conkright JJ. Function of surfactant proteins B and C. Annu Rev Physiol 2001;63:555-78.
10. Nogee LM. Genetics of the hydrophobic surfactant proteins. Biochim Bio-phys Acta 1998;1408:323-33.
11. Khoor A, Stahlman MT, Gray ME, Whitsett JA. Temporal-spatial distribution of SP-B and SP-C proteins and mRNAs in developing respiratory epithelium of human lung. J Histochem Cytochem 1994;42:1187-99.
12. Kormann MS, Hasenpusch G, Aneja MK, et al. Expression of therapeutic proteins afer delivery of chemically modifed mRNA in mice. Nat Biotech-nol 2011;29:154-7.
13. Tafel O, Latzin P, Paul K, Winter T, Woischnik M, Griese M. Surfactant proteins SP-B and SP-C and their precursors in bronchoalveolar lavages from children with acute and chronic infammatory airway disease. BMC Pulm Med 2008;8:6.
14. Beers M F, Fisher AB. Surfactant protein C: a review of its unique properties and metabolism. Am J Physiol 1992;263:L151-60.
15. Kröner C, Reu S, Teusch V, et al. Genotype alone does not predict the clinical course of SFTPC defciency in paediatric patients. Eur Respir J 2015;46:197-206.
16. Griese M, Schumacher S, Tredano M, et al. Expression profiles of hydro-phobic surfactant proteins in children with difuse chronic lung disease. Respir Res 2005;6:80.
17. Tredano M, van Elburg RM, Kaspers AG, et al. Compound SFTPB 1549C-GAA (121ins2) and 457delC heterozygosity in severe congenital lung disease and surfactant protein B (SP-B) defciency. Hum Mutat 1999;14:502-9.
18. Tredano M, Griese M, de Blic J, et al. Analysis of 40 sporadic or familial neonatal and pediatric cases with severe unexplained respiratory distress: relationship to SFTPB. Am J Med Genet A 2003;119A:324-39.
19. Touvenin G, Abou Taam R, Flamein F, et al. Characteristics of disorders associated with genetic mutations of surfactant protein C. Arch Dis Child 2010;95:449-54.
20. Tredano M, Griese M, Brasch F, et al. Mutation of SFTPC in infantile pulmonary alveolar proteinosis with or without fbrosing lung disease. Am J Med Genet A 2004;126A:18-26.
21. Flamein F, Rifault L, Muselet-Charlier C, et al. Molecular and cellular characteristics of ABCA3 mutations associated with difuse parenchymal lung diseases in children. Hum Mol Genet 2012;21:765-75.
22. Kleinlein B, Griese M, Liebisch G, et al. Fatal neonatal respiratory failure in an infant with congenital hypothyroidism due to haploinsufciency of the NKX2-1 gene: alteration of pulmonary surfactant homeostasis. Arch Dis Child Fetal Neonatal Ed 2011;96:F453-6.
23. Wambach JA, Yang P, Wegner DJ, et al. Surfactant protein-C promoter variants associated with neonatal respiratory distress syndrome reduce transcription. Pediatr Res 2010;68:216-20.
24. Schuerman FA, Griese M, Gille JP, Brasch F, Noorduyn LA, van Kaam AH. Surfactant protein B defciency caused by a novel mutation involving multiple exons of the SP-B gene. Eur J Med Res 2008;13:281-6.
25. Dunbar AE 3rd, Wert SE, Ikegami M, et al. Prolonged survival in hereditary surfactant protein B (SP-B) defciency associated with a novel splicing mutation. Pediatr Res 2000;48:275-82.
26. Ballard PL, Nogee LM, Beers MF, et al. Partial defciency of surfactant protein B in an infant with chronic lung disease. Pediatrics 1995;96:1046-52.
27. Akinbi HT, Breslin JS, Ikegami M, et al. Rescue of SP-B knockout mice with a truncated SP-B proprotein. Function of the C-terminal propeptide. J Biol Chem 1997;272:9640-7.
28. Simonato M, Baritussio A, Pioselli B, et al. Surfactant protein C metabolism in human infants and adult patients by stable isotope tracer and mass spectrometry. Anal Bioanal Chem 2014;406:6225-33.
29. Simonato M, Baritussio A, Vedovelli L, Lamonica G, Carnielli V P, Cogo PE. Surfactant protein B amount and kinetics in newborn infants: an optimized procedure. J Mass Spectrom 2012;47:1415-9.
30. Griese M, Dietrich P, Reinhardt D. Pharmacokinetics of bovine surfactant in neonatal respiratory distress syndrome. Am J Respir Crit Care Med 1995;152:1050-4.
31. Griese M, Essl R, Schmidt R, et al.; BEAT Study Group. Pulmonary surfactant, lung function, and endobronchial infammation in cystic fbrosis. Am J Respir Crit Care Med 2004;170:1000-5.
32. Griese M, Felber J, Reiter K, et al. Airway infammation in children with tracheostomy. Pediatr Pulmonol 2004;37:356-61.
33. Paschen C, Reiter K, Stanzel F, Teschler H, Griese M. Terapeutic lung lavages in children and adults. Respir Res 2005;6:138.
34. Brasch F, Birzele J, Ochs M, et al. Surfactant proteins in pulmonary alveolar proteinosis in adults. Eur Respir J 2004;24:426-35.
35. Doan ML, Elidemir O, Dishop MK, et al. Serum KL-6 diferentiates neuro-endocrine cell hyperplasia of infancy from the inborn errors of surfactant metabolism. Torax 2009;64:677-81.
36. Rice A, Tran-Dang MA, Bush A, Nicholson AG. Difuse lung disease in infancy and childhood: expanding the chILD classifcation. Histopathol-ogy 2013;63:743-55.
37. Griese M. Pulmonary surfactant in health and human lung diseases: state of the art. Eur Respir J 1999;13:1455-76.
38. Brasch F, Schimanski S, Mühlfeld C, et al. Alteration of the pulmonary surfactant system in full-term infants with hereditary ABCA3 defciency. Am J Respir Crit Care Med 2006;174:571-80.
39. Torwarth A, Schnittert-Hübener S, Schrumpf P, et al. Comprehensive genotyping and clinical characterisation reveal 27 novel NKX2-1 mutations and expand the phenotypic spectrum. J Med Genet 2014;51: 375-87.